Management of choroid plexus tumours: A comprehensive study from a tertiary hospital.


Journal

Clinical neurology and neurosurgery
ISSN: 1872-6968
Titre abrégé: Clin Neurol Neurosurg
Pays: Netherlands
ID NLM: 7502039

Informations de publication

Date de publication:
02 2021
Historique:
received: 21 09 2020
revised: 17 11 2020
accepted: 24 12 2020
pubmed: 15 1 2021
medline: 22 6 2021
entrez: 14 1 2021
Statut: ppublish

Résumé

Choroid plexus tumours (CPT) are rare intraventricular tumours representing less than 0.5 % of brain tumours. The tumour is commonly located in the supratentorial region, but the location varies depending on the age. We present our experience of managing these tumours in a tertiary hospital. Retrospectively, we reviewed our operative database and recruited 80 cases of CPT who underwent surgical treatment in our institute from 1995 to 2018. We analysed the factors affecting the outcome and the perioperative complications of the choroid plexus tumour. A total of 80 choroid plexus tumours were recruited in our retrospective review, of which 44 were choroid plexus papilloma (CPP), 13 were atypical choroid plexus tumours (ACPP), 23 were choroid plexus carcinomas (CPC). The mean age was 16.75 (SD 16.71) in the overall cohort. Males were found to be predominant in all tumour groups (M/F: 46/34). Headache was the most common symptom (52.5 %). Hydrocephalus was seen in 53.8 % of cases. The median overall survival was 89.88 months. Gross total resection was achieved in 62.5 % cases (n = 50/80), and near-total resection in 27. 5 % cases (n = 22/80). The median overall survival was 89.88 months. The median overall survival for CPP, ACPP, CPC was 106.83, 37.37, 36.19 months, respectively. Median Event-free survival was 65.83 months. A Cox regression analysis of predictors of overall survival of atypical CPP and CPC was done, in which age, sex, location, size, the extent of the resection, and complications were considered. The extent of the resection (p = 0.01) and the size (p = 0.02) were related to overall survival CONCLUSION: CPT's are the rare intraventricular tumours, which requires aggressive resection strategies. The extent of resection offers survival benefit based on the histological grades.

Identifiants

pubmed: 33444945
pii: S0303-8467(20)30797-6
doi: 10.1016/j.clineuro.2020.106454
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106454

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Subhas K Konar (SK)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Sandeep Kandregula (S)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Manish Beniwal (M)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Nishanth Sadashiva (N)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Kautilya Rajendra Kumar Patel (KRK)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Madhusudhan Nagesh (M)

Department of Neurosurgery, NIMHANS, Bangalore, India.

K V L N Rao (KVLN)

Department of Neurosurgery, NIMHANS, Bangalore, India. Electronic address: neuronarsi@gmail.com.

V Vikas (V)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Prabhu Raj (P)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Abhinith Shashidhar (A)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Alok Mohan Uppar (AM)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Dhaval Shukla (D)

Department of Neurosurgery, NIMHANS, Bangalore, India.

B Indira Devi (B)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Dwarakanath Srinivas (D)

Department of Neurosurgery, NIMHANS, Bangalore, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH